Long-term Outcome of Chondrosarcoma: A Single Institutional Experience.
- Author:
Srimanth BINDIGANAVILE
1
;
Ilkyu HAN
;
Ji Yeon YUN
;
Han Soo KIM
Author Information
- Publication Type:Original Article
- Keywords: Chondrosarcoma; Prognosis; Recurrence; Pelvis; Histology
- MeSH: Chondrosarcoma*; Curettage; Follow-Up Studies; Humans; Pelvis; Prognosis; Recurrence; Retrospective Studies; Skeleton
- From:Cancer Research and Treatment 2015;47(4):897-903
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The prognostic factors of chondrosarcoma remain uncertain as only a few large studies with long-term follow-up have been reported. The aim of this study was to analyze oncological outcomes and prognostic factors. MATERIALS AND METHODS: A retrospective review of oncological outcomes and prognostic factors was performed on 125 consecutive chondrosarcoma patients who underwent surgery at our institution. RESULTS: Overall survival was 91.6%+/-2.5%, 84.1%+/-3.8%, and 84.1%+/-3.8% at 5, 10, and 15 years respectively. Among the histological types, dedifferentiated type showed the worst survival (p < 0.001). As for conventional type chondrosarcoma, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome (p < 0.001). In contrast, low-grade chondrosarcoma of appendicular skeleton could be treated safely by intralesional curettage. CONCLUSION: Histological type was significantly associated with the outcome of chondrosarcoma. For the conventional type, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome.
